Catalog No.
AHA02801
Biological activity
Measured by its ability to bind biotinylated recombinant mouse Wnt-3a in a functional ELISA with an ED50 of 15-90 ng/mL.
Expression system
Mammalian Cells
Species
Homo sapiens (Human)
Protein length
Leu23-Asp185
Nature
Recombinant
Endotoxin level
<0.1 EU/μg of the protein by the LAL method.
Purity
>90% as determined by SDS-PAGE.
Accession
O00144
Applications
Bioactivity, ELISA, Immunogen, SDS-PAGE, WB
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 5% Trehalose, 5% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
FzE6, Frizzled-9, FZD9, FZD3, hFz9, CD349, Fz-9
CD9/SOX2-positive cells in the intermediate lobe of the rat pituitary gland exhibit mesenchymal stem cell characteristics., PMID:39808267
Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells., PMID:21047215
Identification of human placenta-derived mesenchymal stem cells involved in re-endothelialization., PMID:20658518
Expression profile of the embryonic markers nanog, OCT-4, SSEA-1, SSEA-4, and frizzled-9 receptor in human periodontal ligament mesenchymal stem cells., PMID:20458727
Prospective isolation of mesenchymal stem cells from multiple mammalian species using cross-reacting anti-human monoclonal antibodies., PMID:20367498
Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody., PMID:17924962
Novel markers for the prospective isolation of human MSC., PMID:17395729
Effects of CD-349 and 8-BrcGMP on isoproterenol-induced relaxation in rabbit aorta precontracted with endothelin-1., PMID:1329561
Protein kinase C-mediated contraction in rabbit aorta is inhibited by CD-349, a dihydropyridine derivative., PMID:1713994
Effects of a novel Ca2+ entry blocker, CD-349, and TMB-8 on renal vasoconstriction induced by angiotensin II and vasopressin in dogs., PMID:1704991
Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin., PMID:2167684
Mechanisms of inhibitory effects of CD-349 and K(+)-channel activators on noradrenaline-induced contraction and changes in levels of cyclic GMP in rat aorta., PMID:2177435
Alteration of cyclic GMP metabolism by CD-349, a novel calcium antagonist, and by sodium nitroprusside in bovine intrapulmonary artery and vein., PMID:2545208
A new Ca-antagonist, CD-349, binding to the Ca-channel of rat myocardium and brain and hog coronary artery., PMID:2854176
Different sensitivities of Ca2+, calmodulin-dependent cyclic nucleotide phosphodiesterases from rabbit aorta and brain to dihydropyridine calcium channel blockers., PMID:2825687
Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by CD-349, a novel 1,4-dihydropyridine derivative: effect of EGTA on the inhibitory activity., PMID:2830423
For research use only. Not for human or drug use.
